Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Total Debt (2016 - 2022)

Nephros has reported Total Debt over the past 9 years, most recently at $171000.0 for Q4 2022.

  • Quarterly results put Total Debt at $171000.0 for Q4 2022, down 50.15% from a year ago — trailing twelve months through Dec 2022 was $171000.0 (down 50.15% YoY), and the annual figure for FY2022 was $171000.0, down 50.15%.
  • Total Debt for Q4 2022 was $171000.0 at Nephros, up from $141000.0 in the prior quarter.
  • Over the last five years, Total Debt for NEPH hit a ceiling of $1.8 million in Q4 2018 and a floor of $141000.0 in Q3 2022.
  • Median Total Debt over the past 5 years was $621500.0 (2020), compared with a mean of $707600.0.
  • Biggest five-year swings in Total Debt: soared 37.38% in 2018 and later tumbled 65.36% in 2022.
  • Nephros' Total Debt stood at $1.8 million in 2018, then crashed by 50.22% to $913000.0 in 2019, then decreased by 22.12% to $711000.0 in 2020, then tumbled by 51.76% to $343000.0 in 2021, then tumbled by 50.15% to $171000.0 in 2022.
  • The last three reported values for Total Debt were $171000.0 (Q4 2022), $141000.0 (Q3 2022), and $410000.0 (Q2 2022) per Business Quant data.